New Thallion - Biotech Industry
Tax losses conversion into cash provides a several benefits.
Fund and finish trial
Makes New Thallion a sure survivor from this biotech meltdown
Give leverage to barganning power
Before:
No cash, good GBM trial = Take Over at a rip off price
After:
Cash and good GBM trial = Take over at fair price.
The deal will be sealed and done. Market will get confirmation from Management (official confirmation) that they are still negociating the sale of the company.
I know that they are.
Official confirmation to be done in July...
That's reality.
232 issue to be soon resolved once and for all, we are now entering arbitration.
I am more bullish on the 232 trial and this product should have been the lead product...
Now for 4601, each day is a validation of trial effectiveness... The trial is about measuring "survival" rate of terminally ill GBM patients....
We have passed way beyond the failure period.